{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph.\n\nParagraph: While nocistatin ( 0 . 5 - 5 . 0 nmol mouse - 1 , i . c . v . ) administered 30 min before spontaneous alternation performance or the training session of the passive avoidance task , had no effect on spontaneous alternation or passive avoidance behaviours , a lower per cent alternation and shorter median step - down latency in the retention test were obtained in nociceptin ( 1 . 5 and / or 5 . 0 nmol mouse - 1 , i . c . v . ) - treated normal mice .\n\nLet's think step by step."},
    {"role": "assistant", "content": "1. Nocistatin: This term appears in the context of being administered to mice, but it is not described as a disease.\n2. Nociceptin: Similar to nocistatin, this term refers to a substance used in the experiment, not a disease.\n3. Spontaneous alternation performance or the training session of the passive avoidance task: These are behavioral tasks used to evaluate memory and learning in mice, not diseases.\n\nThere are no \"Disease\" entities in the provided paragraph."},
    {"role": "user", "content": "Please remove irrelevant entities and only keep the entities that clearly refer to Disease."},
    {"role": "assistant", "content": "There are no disease entities in the provided paragraph."},
    {"role": "user", "content": "Please present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| There are no disease entities in the provided paragraph. |"}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph.\n\nParagraph: While nocistatin ( 0 . 5 - 5 . 0 nmol mouse - 1 , i . c . v . ) administered 30 min before spontaneous alternation performance or the training session of the passive avoidance task , had no effect on spontaneous alternation or passive avoidance behaviours , a lower per cent alternation and shorter median step - down latency in the retention test were obtained in nociceptin ( 1 . 5 and / or 5 . 0 nmol mouse - 1 , i . c . v . ) - treated normal mice .\n\nLet's think step by step."},
    {"role": "assistant", "content": "1. Nocistatin: This is a chemical, specifically a neuropeptide that is involved in pain modulation.\n2. 0.5 - 5.0 nmol: This refers to the amount of nocistatin administered, where nmol stands for nanomole, a unit of measurement for amount of substance.\n3. Nociceptin: This is another chemical, also a neuropeptide that is involved in pain modulation.\n4. 1.5 and/or 5.0 nmol: This refers to the amount of nociceptin administered, where nmol stands for nanomole, a unit of measurement for amount of substance.\n\nThese are the chemical entities in the given paragraph."},
    {"role": "user", "content": "Please remove irrelevant entities and only keep the entities that clearly refer to Chemical."},
    {"role": "assistant", "content": "1. Nocistatin\n2. Nmol (nanomole, unit of measurement for amount of substance)\n3. Nociceptin\n\nThese are the chemical entities in the given paragraph. The other entities such as \"mouse\", \"i.c.v.\", \"per cent alternation\", \"median step-down latency\", \"retention test\" are not chemicals, but rather describe the experimental conditions or behavioral measures."},
    {"role": "user", "content": "Please present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| Nocistatin |\n| Nmol (nanomole, unit of measurement for amount of substance) |\n| Nociceptin |"}
  ]
}